Extracellular inorganic pyrophosphate (PP i) is a potent suppressor of physiological calcification in bone and pathological calcification in blood vessels. Ectonucleotide pyrophosphatase/phosphodiesterases (eNPPs) generate PPi via the hydrolysis of ATP released into extracellular compartments by poorly understood mechanisms. Here we report that cultured vascular smooth muscle cells (VSMC) from rat aorta generate extracellular PP i via an autocrine mechanism that involves ATP release tightly coupled to eNPP activity. The nucleotide analog ␤,␥-methylene ATP (MeATP or AMPPCP) was used to selectively suppress ATP metabolism by eNPPs but not the CD39-type ecto-ATPases. In the absence of MeATP, VSMC generated extracellular PP i to accumulate Ն600 nM within 2 h while steadily maintaining extracellular ATP at 1 nM. Conversely, the presence of MeATP completely suppressed PPi accumulation while increasing ATP accumulation. Probenecid, which inhibits PP i efflux dependent on ANK, a putative PPi transporter or transport regulator, reduced extracellular PP i accumulation by approximately twofold. This indicates that autocrine ATP release coupled to eNPP activity comprises Ն50% of the extracellular PP i-generating capacity of VSMC. The accumulation of extracellular PP i and ATP was markedly attenuated by reduced temperature but was insensitive to brefeldin A, which suppresses constitutive exocytosis of Golgiderived secretory vesicles. The magnitude of extracellular PP i accumulation in VSMC cultures increased with time postplating, suggesting that ATP release coupled to PP i generation is upregulated as cultured VSMC undergo contact-inhibition of proliferation or deposit extracellular matrix. adenosine 5Ј-triphosphate release; vascular calcification; ectonucleotide pyrophosphatase; ectoadenosine 5Ј-triphosphatase EXTRACELLULAR ATP ACTS AS an agonist for the P2X (44) and P2Y (8, 29, 61) families of nucleotide receptors. To prevent activation of these receptors in resting conditions, concentrations of ATP in extracellular compartments are maintained within a narrow nanomolar range through the coordinated coupling of ATP release mechanisms and metabolism of released ATP via various ectonucleotidases (28, 29) . Recent studies indicate that extracellular ATP metabolism also contributes to the regulation of cardiovascular calcification in blood vessels and valves through generation of inorganic pyrophosphate (PP i ), a potent inhibitor of calcification (22, 51) .
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At micromolar levels, extracellular PP i inhibits the ability of Ca 2ϩ and phosphate (Pi) to form insoluble hydroxyapatite crystals in both in vitro solutions (60) and intact tissues such as aortic rings cultured ex vivo (37) . The importance of extracellular PP i homeostasis in human cardiovascular function is highlighted by the often fatal syndrome of idiopathic infantile arterial calcification (51, 52) that has been linked to inactivating mutations in the ENPP1 gene, which encodes an ectonucleotide pyrophosphatase/phosphodiesterase (eNPP1) also known as PC-1 (57) . Calcification of large-capacitance arteries also markedly disrupts normal cardiovascular hemodynamics in more common human diseases such as renal failure and Type II diabetes (10, 45, 56) .
The suppressive effect of PP i on pathological calcification in soft tissues, such as blood vessels, requires its regulated accumulation within local extracellular compartments, and three distinct plasma membrane proteins regulate this local accumulation. These include eNPP1 (59) , which catabolizes extracellular ATP to produce PP i , and tissue nonselective alkaline phosphatase (TNAP), which hydrolyzes PP i into phosphate and thereby opposes the action of eNPP1 (40) . The progressive ankylosis disease susceptibility gene product (ANK) is a plasma membrane protein that either directly mediates efflux of cytosolic PP i or regulates the activity of another as-yet-undefined PP i transporter (17) . Thus, sustained activities of NPP1 and/or ANK are required for the active, steady-state suppression of pathological calcification in soft tissues. TNAP is a marker protein for osteoblasts and, via its ability to clear locally generated PP i , facilitates normal mineralization of bone (15) . Similarly, aberrant accumulation of TNAP-expressing cells within vascular lesions can promote arterial calcification (10, 45, 56) .
Calcification of large arteries in rodents can be induced by experimental manipulations that induce renal failure or conditions, such as hyperphosphatemia and hyperparathyroidism, which accompany chronic kidney disease (38, 42) . The capacity of PP i -regulatory proteins to counteract vascular calcification is also contingent on local extracellular matrix proteins and the ambient levels of Ca 2ϩ and Pi (13, 33) . While deletion of eNPP1 or inactivation of ANK predisposes mice to aortic calcification (22) , the rate and severity of calcification is greatly potentiated when enpp1 Ϫ/Ϫ or ank mice are fed a high-phosphate diet (42) .
That loss of either eNPP1 or ANK activity potentiates vascular calcification suggests that these proteins act in non-redundant, parallel pathways for the maintenance of appropriate extracellular PP i homeostasis. Johnson et al. (22) observed that steady-state levels of PP i in the conditioned media of cultured aortic vascular smooth muscle cells (VSMC) from either enpp1 Ϫ/Ϫ or ank mice were similarly reduced by ϳ50%, relative to wild-type cultures, during induction of in vitro calcification by elevated phosphate. However, increased phosphate also alters expression of both eNPP1 and ANK (18) . Thus, the relative contribution of the eNPP1 versus ANK pathway to extracellular PP i generation by VSMC in the basal state is unclear.
ENPP1 is part of a broader purinergic signaling network in blood vessels that regulates not only calcification but also vascular tone, inflammation, and remodeling (8) . Notably, the source and mechanism for delivery of the extracellular ATP that drives eNPP1-mediated generation of PP i in vascular compartments remains undefined. Here we characterize an autocrine pathway of ATP release that is tightly coupled to the production of extracellular PP i in a rat aortic VSMC model. Our data indicate that eNPP1-mediated hydrolysis of endogenous ATP released from VSMC operates in parallel with another pathway involving direct efflux of intracellular PP i to maintain extracellular PP i levels in the micromolar range.
EXPERIMENTAL PROCEDURES
Materials. Low-glucose (1 g/l) Dulbecco's modified Eagle's medium (LG-DMEM), firefly luciferase assay mix (FL-AAM), ATP standards (FL-AAS), sodium pyrophosphate, adenosine 5Ј-phosphosulfate (APS), adenosine-5Ј-triphosphate sulfurylase (ATP-sulfurylase), ␤,␥-methylene ATP (MeATP or AMPPCP), probenecid (PB), brefeldin A (BFA), levamisole, methylene diphosphonate (PCP), and TRIzol were from Sigma-Aldrich (St. Louis, MO); 1,N 6 -ethenoadenosine 5Ј-triphosphate (ε-ATP) was from Invitrogen/Molecular Probes (Eugene, OR). Fetal bovine serum, newborn calf serum (CS), and penicillin-streptomycin (P/S) were from Hyclone (Logan, UT). Oligo(dT) 15 primer and RNase inhibitor were purchased from Promega (Madison, WI). Avian myeloblastosis virus (AMV) reverse transcriptase, Taq polymerase, and PCR nucleotide mix were from Roche (Indianapolis, IN) while the dNTP mix was from Stratagene. PCR primers were obtained from Operon Biotechnologies (Huntsville, AL). Anti-human eNPP1 (L-20), anti-green fluorescent protein (GFP) (FL), and anti-actin (C-11) primary antibodies and secondary antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA , male) were anesthetized by intraperitoneal injection of a saturated pentobarbital sodium solution (40 mg/kg body wt). Following achievement of deep anesthesia, the chest was opened and the thoracic aorta was rapidly removed under aseptic surgical conditions. Rat aortic VSMC were isolated using an explanted aortic ring model previously described (11) . All subsequent steps were performed using a dissection microscope in a cell culture hood under sterile airflow. The adventitial and endothelial layers were gently removed, and the aorta was sectioned into 2-to 3-mm rings and placed onto the prescratched (by a scalpel blade) and washed surfaces of wells within a six-well culture plate. Three rings were placed per well together with 2 ml growth media (LG-DMEM supplemented with 10% fetal bovine serum, 1% P/S, and 0.11 g/l sodium-pyruvate) and maintained at 37°C in a 10% CO 2 atmosphere. After initial culture for 2 days, the rings were transferred to the wells of a fresh six-well plate and cultured for an additional 5 days during which significant outgrowth of VSMC was observed. These primary VSMC were then passed weekly by trypsinization and 1:4 splits for subculture. Unless otherwise noted, experiments were performed using VSMC at passages 2-4. The cells were Ն95% positive for smooth muscle ␣-actin as measured by immunofluorescence (data not shown).
HEK-293 cells were stably transfected with expression plasmids encoding either GFP or human eNPP1. The transfected HEK-293 lines were selected and maintained in the presence of G418 (400 g/ml) in DMEM supplemented with 10% CS and antibiotics. Mouse L-cells differentiated by culture in the presence of 1 mM 8-chlorophenylthio-cyclic AMP (CPT-cAMP) for 2 days were used as positive control cells that express TNAP at high levels (5) .
RT-PCR analysis of ectonucleotidase subtypes. Semiquantitative RT-PCR was used to compare the expression profiles of ectonucleotidases and PP i homeostatic proteins in the cultured VSMC. Total RNA was isolated using TRIzol following the manufacturer's protocol. First-strand cDNA synthesis was accomplished using 1-2 g total RNA, primed with 1 g oligo(dT) primer, and incubated with 2 units AMV reverse transcriptase, 8 mM dNTPs, and 1 unit RNase inhibitor at 42°C for 1 h. The following cDNA transcripts were analyzed: eNPTDase1/CD39, eNTPDase2, eNTPDase3, eNPP1/PC1, eNPP3/ B10/gp130, CD73, TNAP, and ANK. The PCR primer pairs and amplicon sizes for the various ectonucleotidases have been previously reported (25) . The primer pair (5Ј-GCCGCTGCTCATCCCCATCC, antisense, 5Ј-GGCCGAGGTGACCGTGTTGTTC) used to analyze ANK cDNA transcripts was designed using DNAStar v.5 (DNASTAR) to produce a 400-bp ANK amplicon. Glyceraldehyde phosphate dehydrogenase was used as a high-copy housekeeping gene product. PCR reactions were performed in 20-l reaction volumes containing 10-fold dilutions of RT reaction product (1:10 to 1:10,000) with 10 mM Tris⅐HCl (pH 8.3), 1.5 mM MgCl2, 50 mM KCl, 250 M dNTPs, 1 M primer mix, and 2.5 U/l Taq DNA polymerase. PCR running conditions were as follows: 94°C for 2 min, followed by 35 cycles of 94°C for 40 s, 58°C for 40 s, and 74°C for 3 min with a final extension step for 5 min at 37°C. PCR products were electrophoretically separated on 1.5% agarose gels containing ethidium bromide (1 g/ml), and the fluorescent bands were visualized and recorded with a Bio-Rad GelDoc 1000 detector.
Ectonucleotidase assays. Ecto-ATPase activities of VSMC (as adherent monolayers) or HEK-293 cells (as trypsin-detached suspensions) were monitored by luciferase-based methods. HEK-293 cells (10 6 ) were resuspended in 200 l basal salt solution (BSS) containing (in mM) 130 NaCl, 5 KCl, 1.5 CaCl2, 1 MgCl2, 25 Na-HEPES (adjusted to pH 7.5 at room temperature, 22-24°C), 5 glucose, and 0.1% BSA, supplemented with 8 l from a concentrated luciferase/ luciferin stock solution (FL-AAM). The cell suspensions were then pulsed with 100 -500 nM exogenous ATP; decreases in ATP-dependent luminescence over the next 20 -30 min were continuously monitored using a Turner Designs (TD 20/20) luminometer. Where indicated, the cell suspensions were supplemented with 300 M MeATP immediately before addition of the ATP pulse. Ecto-ATPase activities of adherent VSMC were performed using cell monolayers (0.3-0.6 ϫ 10 6 cells/well of 6-well plates) bathed in 1 ml BSS. These experiments were performed at 37°C in the absence or presence of 300 M MeATP. The cells were preincubated for 20 -30 min to clear endogenously released ATP before the addition of exogenous ATP. Extracellular samples (100 l) taken at various times after ATP addition were boiled for 5 min (to inactivate any shed ectonucleotidase activity) and then stored on ice before analysis of ATP and PPi levels as described below.
Enzyme assays for quantitation of ATP and PPi levels in extracellular medium samples. To quantitate extracellular PPi we adapted an enzyme-linked bioluminescence assay originally developed to detect liberated PPi from RNA reverse transcription reactions (27, 50) . In this assay system, PP i reacts with APS in the presence of ATPsulfurylase to generate ATP which is measured by a coupled luciferin/ luciferase reaction. Our adaptation of this assay facilitated quantitative measurements of both the ATP and PP i content within the same sample of extracellular medium. Briefly, 75 l of heat-inactivated (100°C, 5 min) extracellular sample was mixed with 20 l of 25 M APS, and 4 l concentrated FL-AAM to yield a final reaction volume of 99 l (with 5 M APS). The initial steady-state bioluminescence, measured at room temperature with the TD 20/20 luminometer, was an indicator of the ATP content in the extracellular medium sample. When this initial ATP-dependent bioluminescence reached a steady value, ATP-sulfurylase (0.01 units in 1 l) was added to drive conversion of PPi to ATP, and bioluminescence was continuously measured until a new steady state was reached. This value was recorded and subtracted from the original ATP-dependent bioluminescence value to yield PPi-dependent bioluminescence. Calibration curves were generated for each experiment using identical coupled enzymes reactions with BSS containing ATP and PP i standards (1 nM to 1 M) in place of the cell-conditioned media samples. For extracellular samples containing pharmacological inhibitors of ATP release pathways or ectonucleotidases, additional calibration curves were generated in the presence of the indicated inhibitor to assess possible inhibitory effects on the ATP-sulfurylase or luciferase reactions.
This assay system was also used to measure extracellular ATP and PPi concentrations produced endogenously by rat aortic VSMC. For these experiments, unless otherwise stated, adherent monolayers of rat aortic VSMC (0.3-0.6 ϫ 10 6 cells/well) were used between passages 2 and 4 and 3-9 days postplating on six-well plates at 37°C. For these experiments, the cell monolayers were rapidly washed twice with PBS (after aspiration of tissue culture medium) and then transferred to 1.2 ml fresh BSS to initiate the test incubations at 37°C in the absence or presence of the indicated inhibitor(s). An initial 100-l aliquot of extracellular media was immediately taken (ϳ1-to 3-min time point), and additional 100-l samples were taken at various intervals (5-60 min as indicated in specific experiments) for up to 2 h after transfer of the cells to the BSS test medium. Each extracellular medium sample was heated (100°C, 5 min) and centrifuged before quantitative analysis of ATP and PPi content.
Alkaline phosphatase activity in lysates of VSMC or CPT-cAMPdifferentiated L-cells was assayed in the absence or presence of levamisole by previously described methods (5, 38) .
Ectonucleotidase assays by high-performance liquid chromatography. Reverse-phase high-performance liquid chromatography (HPLC) was used to measure the extracellular metabolism of fluorescent, etheno-derivitized, adenine nucleotide analogs ε-ATP (Molecular Probes) and ε-MeATP (25, 31) . Cell monolayers were grown in six-well tissue culture plates, washed twice with 1 ml PBS pH 7.4, and equilibrated for 30 min in 1 ml BSS at room temperature. Cells (HEK-293 or VSMC) were then pulsed with indicated concentrations of either ε-ATP or ε-MeATP. At indicated time points, 100 l of extracellular medium were removed and boiled for 5 min. Adenine nucleotide derivatives were resolved using an Alltech C18 Ad-sorbosphere column eluted at 1.3 ml/min. A methanol gradient was formed by mixing buffer A (0.1 M KH2PO4, pH 6, 5% methanol) with buffer B (0.1 M KH 2PO4, pH 6, 15% methanol) using the following protocol: 0 -2 min (100% buffer A); 2-3 min (ramp to 75% buffer A/25% buffer B); 3-26 min (ramp to 35% buffer A/65% buffer B); 26 -30 min (ramp to 100% buffer A). Fluorescent adenine analogs were detected with a Linear LC305 fluorescence detector using 270 nm excitation and 410 nm emission wavelengths. Alternatively, isocratic reverse-phase HPLC was used to assay the extracellular metabolism of 300 M MeATP by VSMC monolayers grown in six-well dishes. Extracellular samples were processed as described before injection onto the Alltech C18 column. Nucleotides were resolved by isocratic elution (1.3 ml/min) with buffer A and detected by absorbance at 254 nm.
Western blot analysis. Adherent cultures of HEK-293 cells or VSMC were extracted and analyzed by SDS-PAGE and Western blotting using previously described methods (3) .
Statistical analysis. All experiments with VSMC were repeated at least three times using different preparations of cultured VSMC. All data, unless otherwise stated, represent means Ϯ SE, and statistical significance was defined as P Ͻ 0.05 using two-or three-way ANOVA with the Bonferroni post hoc test.
RESULTS
Clearance of extracellular ATP is coupled to PP i accumulation in rat aortic VSMC. We used rat aortic VSMC at low passage number (2-4) as a tissue culture model for quantitatively assaying extracellular ATP release and metabolism and coupled PP i accumulation. These cultures expressed smooth muscle-specific ␣-actin in Ͼ95% of the cells for at least six passages, as well as mRNA for multiple VSMC gene markers, including smooth muscle myosin-1 heavy chain, SM22-␣, caldesmon, and calponin (data not shown). Analysis of mRNA transcripts for different ectonucleotidase subtypes indicated significant expression of eNPP1, NTPDase3, and CD73, while TNAP, NTPDase1 (CD39), and eNPP3 were present at lower levels (Fig. 1A) ; mRNA for the ANK PP i transporter/regulator was also abundant. The intact VSMC expressed robust ectoATPase activity as indicated their ability to completely hydrolyze an exogenously added pulse of 100 nM ATP within 10 min (Fig. 1B) . Notably, the rate at which the VSMC hydrolyzed extracellular ATP was reduced twofold in the presence of MeATP (also known as AMPPCP). We previously reported that MeATP selectively suppresses the catabolism of extracellular ATP by eNPP-family, but not CD39-family, ectoATPases in several rat and human cell types (3, 24, 25) . EctoATPase measurements in HEK-293 cells stably transfected with human eNPP1 verified this selectivity of MeATP (supplemental Fig. 1 ; supplemental data and online article are available at the American Journal of Physiology-Cell Physiology website). To demonstrate that eNPP1 in VSMC functions as a PP i -generating ecto-ATPase, we pulsed monolayers of adherent cells (ϳ5 ϫ 10 5 cells⅐ml Ϫ1 ⅐35-mm dish Ϫ1 ) with 10 M ATP in the absence or presence of MeATP (300 M) and measured extracellular levels of both ATP and PP i over a 60-min test period. The 10 M pulse of exogenous ATP was almost completely cleared by the VSMC monolayers within 60 min (Fig. 1C) and correlated with the progressive accumulation of extracellular PP i (Fig. 1D) . However, the extracellular PP i concentration ([PP i ]) at 60 min was only 3 M, indicating that only 30% of the hydrolyzed ATP was coupled to PP i generation or that PP i itself was further metabolized. MeATP modestly retarded clearance of the 10 M ATP pulse (Fig. 1C) but completely suppressed the accumulation of PP i (Fig. 1D ). This indicates that rat aortic VSMC express MeATP-sensitive eNPP-family ectonucleotidases that generate extracellular PP i as an end-product and also MeATP-insensitive NTDPasefamily ecto-ATPases that produce P i rather than PP i . Direct analysis of P i production with 500 M ATP as the substrate indicated an ecto-ATPase rate of 3.23 Ϯ 0.12 nmol⅐h Ϫ1 ⅐g protein Ϫ1 in the absence of MeATP versus an ecto-ATPase of 3.38 Ϯ 0.26 nmol⅐h Ϫ1 ⅐g protein Ϫ1 in the presence of 300 M MeATP.
ATP released from VSMC is efficiently coupled to extracellular PP i accumulation.
Most mammalian cell types constitutively release ATP at low but significant rates thereby conditioning extracellular compartments to contain nanomolar concentrations of ATP and ATP metabolites at steady state (24, 29) . Perturbation of the steady-state relationship between the ATP release rate and the ATP clearance rate, by either increasing the rate of ATP release (e.g., due to mechanical stimulation) or repressing activity of the opposing ecto-ATPases, leads to higher levels of extracellular ATP. We assessed the ability of adherent VSMC to condition their extracellular medium with endogenous ATP and PP i during 2-h test incubations in serum-free BSS. It is important to note that transfer of the VSMC monolayers from the regular tissue culture media to this experimental test media (including two intermediate washes with PBS) constitutes a transient mechanical stimulus that triggers rapid release of endogenous ATP and other lowmolecular-mass metabolites into the extracellular compartment. Thus, Fig. 2 , B (log scale) and C (linear scale), shows that 10 -20 nM extracellular ATP was present at the earliest time point (3 min) at which the assay medium was sampled. Notably, ϳ150 nM extracellular PP i was also rapidly accumulated at this early time point (Fig. 1A) followed by a sustained increase in extracellular [PP i ] to Ͼ600 nM as the VSMC progressively conditioned the assay medium over the 2-h experimental time course (Fig. 2, A and D) . In contrast, the initial burst of accumulated extracellular ATP progressively decreased at the later time points to a steady-state level of 1 nM ATP within 30 min. Notably, when VSMC were transferred to MeATP-containing assay medium, the accumulation of both extracellular ATP (Fig. 2, B and C) and PP i ( Fig. 2A) was markedly altered. Although the initial burst of PP i accumulation was not affected, the VSMC did not accumulate additional extracellular PP i but slowly cleared the initially accumulated PP i . Conversely, inclusion of MeATP reversed the clearance of the initially released ATP and facilitated accumulation of extracellular [ATP] in the 20 -60 nM range during the 2 h of subsequent incubation (Fig. 2, B and C) . These data indicate that VSMC continue to release ATP after the initial mechanical stimulus at a rate that is matched by an opposing MeATPsensitive ecto-ATPase (and MeATP-insensitive ecto-ATPases) to yield a steady-state level of 1 nM extracellular ATP in the absence of MeATP. The sustained increase in extracellular PP i levels during maintenance of this low steady-state ATP level indicates that ATP release from the VSMC is very efficiently coupled to PP i generation via an eNPP-type ecto-ATPase. Suppression of this eNPP-mediated ATP metabolism in the presence of MeATP coordinately blocks accumulation of extracellular PP i and facilitates increased levels of ATP. Tissue nonselective alkaline phosphatase (TNAP) acts as a potent PP i hydrolyzing ectoenzyme (40, 42, 43) . We used 5 mM levamisole, a well-characterized TNAP inhibitor, to test whether basally expressed TNAP significantly limited the magnitude of extracellular PP i accumulation by the cultured VSMC (43) . If TNAP activity is high, then the presence of levamisole should potentiate PP i accumulation. However, this was not observed. In the presence of levamisole, extracellular PP i accumulation (measured at 2 h as described in Fig. 2D ) by intact VSMC was 71 Ϯ 29% (n ϭ 3 experiments) of the normalized values measured in the absence of levamisole. This concentration of levamisole strongly inhibited alkaline phosphatase activity (supplemental Fig. 2) , as measured by standard p-nitrophenyl phosphate hydrolysis assays, in lysates of VSMC or lysates of cAMP-differentiated L-cells that express high levels of TNAP (5) . Notably, the levamisole-sensitive alkaline phosphatase-specific activity in VSMC lysates was ϳ16-fold lower than in L-cell lysates. Thus, basally expressed TNAP is not a major regulator of extracellular PP i homeostasis in cultured VSMC. Direct measurements indicated that exogenous PP i was only slowly cleared (20% of a 1 M pulse was metabolized within 2 h) by these cultured VSMC (data not shown).
Attenuation of extracellular PP i accumulation by methylene diphosphonate, a product of eNPP1-mediated metabolism of MeATP. We previously reported that MeATP inhibits ATP hydrolysis by eNPP-type ecto-ATPases by acting as a competing substrate (25) and have verified this rapid catabolism of extracellular MeATP in both HEK-293 cells stably transfected with human eNPP1 (Fig. 3A) and in rat VSMC (Fig. 3B) . Thus, eNPP1 will catalyze the reaction (MeATP 3 PCP ϩ AMP) to generate PCP, a bisphosphonate analog, as a by-product. In turn, the PCP that accumulates during incubation of VSMC with MeATP may affect the autocrine mechanisms that drive accumulation of extracellular PP i . This was supported by our observation that PP i accumulation was reduced in a dosedependent manner by exogenously added PCP, with 300 M producing an eightfold decrease (Fig. 3C) . Notably, we verified that these concentrations of PCP had no inhibitory actions on either the luciferase or ATP-sulfurylase reactions used to quantitate the PP i levels in conditioned medium. PCP (300 M) by itself did not affect the transient accumulation of extracellular ATP induced by the medium exchange stimulus. Rather, the presence of both PCP and MeATP in the exchange medium further potentiated the marked ATP accumulation facilitated by MeATP alone (Fig. 3D) . This suggests that PCP may act as a product inhibitor of eNPP1 and thereby attenuate both PP i accumulation and ATP clearance.
PCP is similar to the non-nitrogen-containing bisphosphonates used in antiosteoporosis therapy. The therapeutic action of such bisphosphonates involves their accumulation within osteoclasts and intracellular incorporation into cytotoxic ATP analogs via a back reaction with AMP-aminoacyl tRNA synthetase conjugates (48) . We tested whether the observed ability of PCP to suppress accumulation of extracellular PP i by VSMC might involve toxic effects that result in decreased intracellular ATP content. However, exposure of VSMC to 300 M PCP for up to 2 h (the usual duration of the test incubations for measuring PP i accumulation rates) did not result in significant reduction in intracellular ATP levels (Fig. 3E) .
Attenuation of extracellular PP i generation by probenecid. Given the high expression of ANK mRNA in VSMC (Fig. 1A) , we tested the possible contribution of ANK-regulated PP i efflux by comparing PP i accumulation and ATP release in the absence or presence of PB, MeATP, or combined PB plus MeATP. PB acts as an inhibitor of multiple anion transporters and has been shown to reduce PP i efflux mediated or regulated by ANK (17) . Fig. 4 , A and C, shows that extracellular PP i accumulation was reduced twofold in the presence of 2.5 mM PB, which contrasted with the near-complete suppression of PP i generation by MeATP. These experiments indicated that a PB-sensitive mechanism accounts for ϳ50% of the PP i that accumulates in extracellular medium acutely conditioned by VSMC. PB alone had no obvious effect on the initial mechanically induced ATP release or the clearance of this released ATP (Fig. 4B) . However, exposure of VSMC to both PB and MeATP resulted in lower (albeit not statistically significant) accumulation of extracellular ATP (at the later times following medium transfer) compared with cultures incubated with only MeATP (Fig. 4, B and C) . This suggested that the inhibitory effects of PB on PP i levels might additionally involve reduction in the ATP release that is correlated with the MeATPsensitive PP i accumulation.
Accumulation of extracellular PP i and ATP by VSMC is attenuated by reduced temperature but not brefeldin A.
Basal nucleotide release can reflect export of nucleotides contained within the Golgi-derived secretory vesicles that continuously bring new protein and lipid cargo to the plasma membrane (26) . Because secretion of Golgi-derived vesicles is a highly temperature-sensitive process, we tested the effect of reduced incubation temperature (23°C relative to the control 37°C) on PP i accumulation (Fig. 5, A and C) and ATP release (Fig. 5, B and C) by VSMC. These experiments showed that the sustained rate, but not the initial burst, of extracellular PP i accumulation was greatly reduced at the lower assay temperature. This could reflect reduced rates of 1) eNPP1-catalyzed conversion of released ATP to PP i , 2) ANK-dependent PP i efflux, or 3) an ATP release process per se. The latter possibility was supported by reduced ATP accumulation observed at 23°C in the presence of MeATP. Reduced temperature did not decrease the initial burst of ATP released after medium transfer, but no additional accumulation of ATP was observed in the presence of MeATP at 23°C. BFA inhibits the GTP/GDP exchange cycle of ARF-family small GTPases and thereby attenuates anterograde membrane traffic both from the endoplasmic reticulum to the Golgi and from the Golgi to the plasma membrane to suppress constitutive secretion (4, 41) in most cells, including VSMC (39) . Given the marked temperature sensitivity of the PP i and ATP accumulation, we tested whether the effects of reduced temperature would be mimicked by BFA. VSMC were preincubated with 3 g/ml BFA for 2 h before the transfer to serum-free test medium and were also incubated with this concentration of BFA throughout the media conditioning period. The BFA-treated cells were characterized by extracellular PP i accumulation (measured at 2 h as described in Fig. 5C ) that was 86 Ϯ 12% (n ϭ 4 experiments) of the normalized values measured in the absence of BFA. Likewise, BFA treatment did not affect the release or metabolism of extracellular ATP.
PP i accumulation in rat aortic VSMC cultures is modulated by time postplating. The ATP release and PP i accumulation experiments illustrated in Figs. 2-5 used rat aortic VSMC cultures at passages 3-4, and most were performed at ϳ4 days postplating of 4 ϫ 10 5 cells per well of the six-well assay dishes. In vitro calcification experiments routinely involve more prolonged in vitro culture (7-14 days postplating) in the presence of various promineralizing stimuli (e.g., elevated phosphate, osteogenic cytokines) (22) ; the controls for such experiments use VSMC cultured for similarly prolonged times but in the absence of promineralizing factors (13) . We observed increases in the rate and extent of PP i accumulation when control VSMC from the same aortic isolate and passage were assayed at 9 days postplating (Fig. 6, B and D) versus 3 days postplating (Fig. 6, A and D) . Control experiments with cells plated at increasing densities indicated that this effect of time postplating could not be ascribed simply to increased cell numbers per well (data not shown). Differences in PP i accumulation between short-term (3-4 days postplating) versus longer-term (7-9 days) cultures were observed at all passages (Fig. 6D) . This may reflect differences in 1) ATP release, 2) hydrolysis of ATP to PP i by eNPP1, 3) competing hydrolysis of released ATP by ecto-ATPases other than eENPP1, or 4) efflux of intracellular PP i via anion transporters. Figure 6C shows that reduced expression or activity of eNPP1 per se is an unlikely explanation for the low rates of PP i generation observed in shorter-term VSMC cultures because these cells readily generated extracellular PP i via a MeATP-sensitive mechanism when challenged with a 500 nM pulse of exogenous ATP to supplement the ATP released from endogenous stores.
Steady-state PP i accumulation by rat aortic VSMC in tissue culture. The fetal bovine serum used for tissue culture of VSMC contains substantial alkaline phosphatase activity, which efficiently hydrolyzes PP i to P i . In the experiments shown thus far, VSMC were transferred to serum-free assay medium to analyze extracellular PP i and ATP accumulation during short-term (Յ2 h) incubations under defined in vitro conditions. We also tested how VSMC accumulate extracellular PP i when maintained in standard serum-supplemented DMEM-type tissue culture medium (Fig. 7) . Our stocks of DMEM, in the absence of serum or conditioning by cells, contained ϳ2 M PP i as presumed contaminant from added antibiotics or other cofactors. However, the addition of serum, which contains alkaline phosphatase, rapidly reduces this to 100 nM PP i . Rat aortic VSMC maintained in serum-supplemented DMEM steadily conditioned this medium to produce an extracellular level of 10 M PP i within 4 days. The VSMC-conditioned DMEM contained very low (Ͻ1 nM) extracellular ATP due to the combined ecto-ATPase activities of both cells and the serum (data not shown). Thus, VSMC constitutively generate extracellular PP i at a rate sufficient to counteract serum-associated pyrophosphatase activity and thereby elevate PP i to the supramicromolar levels required for suppression of vascular calcification.
DISCUSSION
This study provides the first direct characterization of an autocrine pathway wherein the release of endogenous ATP stores is tightly coupled to extracellular ATP hydrolysis and the sustained accumulation of extracellular pyrophosphate in cultured VSMC. Our experiments indicate that this coupled pathway of ATP release and extracellular hydrolysis operates in synchrony with another autocrine mechanism wherein intracellular PP i , generated as a by-product of multiple intracellular nucleotide-consuming metabolic reactions (60) , is directly released into the extracellular compartment via a probenecid-sensitive transport process. This probenecid-sensitive PP i accumulation may be mediated or regulated by ANK, which is highly expressed in these VSMC. Other results suggest that the expression and/or activities of the signaling proteins that underlie these autocrine pathways of PP i accumulation may be modulated as the growth state of VSMC and their secretion of extracellular matrix elements changes during sustained tissue culture. Taken together, these observations support significant roles for local release of both ATP and PP i in the steady-state suppression of pathological calcification in blood vessels as in the model illustrated in Fig. 8 . Perturbation of either autocrine pathway may contribute to the complex etiology of cardiovascular calcification that is associated with dysregulation of multiple endocrine, paracrine, and metabolic factors (23, 56) .
These data extend previous findings using cultured aortic VSMC isolated from enpp1 Ϫ/Ϫ and ank/ank murine models, which indicated that eNPP1-and ANK-dependent mechanisms provided equal and additive contributions to the accumulation of extracellular PP i (22) . That study used VSMC cultured under promineralizing conditions (elevated extracellular phosphate and reduced serum) that favor upregulation of PP idegrading TNAP, whereas the present experiments used standard synthetic phenotype VSMC that express much lower levels of TNAP. Thus, our finding that a PB-sensitive pathway comprised ϳ50% of the acute PP i -generating capacity in these latter VSMC further suggests that the autocrine ANK and eNPP1 pathways are coordinately utilized for PP i accumulation under both basal conditions and during induction of proosteogenic gene expression. This reinforces in vivo observations that absence of either eNPP1 or ANK predisposes mice to spontaneous aortic calcification and markedly accelerates the aortic mineralization induced by hyperphosphatemia (42) . Although our experiments focused on VSMC, the coordinate roles of eNPP1-and ANK-based pathways in the suppression of mineralization have been most extensively characterized in osteoblasts and chrondrocytes (15, 16) . These latter cells share a mesenchymal stem cell lineage with VSMC, fibroblasts, and adipocytes (21) . ANK expression in murine fibroblasts is increased during growth stimulation in response to multiple mitogens (14) , while downregulation of eNPP1 is required for optimal adipogenic differentiation of murine fibroblasts (34) . Whether similar dynamic regulation of coordinate ATP release, eNPP1, or ANK activity occurs as VSMC switch be- tween contractile and synthetic phenotypes is an important question for future studies.
Our use of MeATP as an experimental tool presented both advantages and limitations. Ecto-ATPases encompass two families of structurally and functionally distinct cell surface proteins: 1) the ectonucleoside 5Ј-triphosphate diphosphohydrolases (NTPDases), which include CD39 (NTPDase1) and four related members (47); and 2) the eNPPs, which include eNPP2 and eNPP3 in addition to eNPP1 (57) . Although both NTPDases and eNPPs can use ATP as a preferred substrate, their catalytic properties are distinct in that NTPDases serially hydrolyze ATP to produce AMP plus two phosphates (P i ) while eNPPs act as pyrophosphatases hydrolyzing ATP to generate AMP plus PP i . RT-PCR analysis and direct measurement of ecto-ATPase activity confirmed that the cultured VSMC express multiple ecto-ATPases (NTPDase1, NTPDase3, and eNPP3) in addition to eNPP1 (Fig. 1 ). At present, there are no selective inhibitors of either ecto-ATPase family (32) . We previously described (and confirmed in this study) pharmacological experiments indicating that MeATP competitively inhibits ATP utilization by eNPPs but not NTPDases (25) . Significantly, recent analysis of the crystal structure of NTPDase2 showed that MeATP/AMPPCP, in contrast to AMPPNP (5Ј-adenylyl-␤,␥-imidodiphosphate), cannot fit into the ATP-binding site of that ecto-ATPase (63) . This explains our findings that even submillimolar MeATP does not affect the hydrolysis of micromolar ATP by cells expressing only NTDPases and no eNPPs (25) (supplemental Fig. 1 ). This extraordinary selectivity also underlies our observation that MeATP completely suppresses the generation of extracellular PP i by VSMC challenged with a 10 M pulse of exogenous ATP while only modestly slowing clearance of this added ATP by the com- bined ecto-ATPase activities of eNPP1, eNPP3, NTPDase1/ CD39, and NTPDase3. It is important to note that MeATP also acts as a substrate for eNPP1-mediated hydrolysis in VSMC (Fig. 3B ) with its by-products being extracellular AMP and PCP. Notably, we observed that PCP, which is a nonhydrolyzable PP i analog, potently inhibited the autocrine accumulation of extracellular PP i by VSMC (Fig. 3C ). Under our experimental conditions, PCP did not suppress ATP accumulation (Fig.  3D) nor did it induce a decrease in intracellular ATP content (Fig. 3E) . These findings indicate that PCP may suppress accumulation of extracellular PP i in two ways: 1) by blocking PP i efflux via ANK; and 2) by acting as a product-inhibitor of eNPP1-mediated hydrolysis of released ATP into PP i and AMP (Fig. 8) . Although short-term PCP exposure did not induce obvious cytotoxic or proapoptotic responses, we have observed that more prolonged incubation (Ͼ6 h) in the presence of PCP induces a significant rounding up and detachment of cultured VSMC. This suggests that PCP may eventually induce proapoptotic effects similar to those triggered by non-nitrogencontaining bisphosphonates.
Extracellular PP i homeostasis and mineralization reactions are further regulated by the expression and functional activity of TNAP, a glycosylphosphatidylinositol-anchored ectoenzyme that degrades locally accumulated extracellular PP i into Pi (40) . However, we observed that the cultured rat aortic VSMC express only low levels of TNAP mRNA (Fig. 1A) and levamisole-sensitive alkaline phosphatase activity (supplemental Fig. 2) . Thus, TNAP does not significantly limit the rate or extent of PP i accumulation during acute medium conditioning in this cultured VSMC model. However, TNAP is markedly upregulated in several VSMC models during culture in the presence of promineralizing stimuli, such as elevated phosphate and various proosteogenic cytokines (33, 43, 46, 58) . A robust levamisole-sensitive pyrophosphatase activity is also observed in freshly isolated rat aortic rings, and this activity is increased in aortic segments derived from uremic rats (38, 43) . Thus, the relative expression of TNAP appears to vary with the well-known phenotype plasticity of VSMC (55): modest expression in the differentiated, contractile phenotype cells that predominate in intact blood vessels or aortic rings, low expression in the proliferating, synthetic phenotype cells that predominate in tissue culture, and high expression in the calcifying phenotype cells that accumulate in response to osteogenic stimuli. However, it remains possible that levamisole-insensitive phosphatase(s) also described in explanted rat aortic rings may act as predominant pyrophosphatases in the synthetic phenotype VSMC (43) .
A major unresolved question is the mechanism(s) by which ATP is released from VSMC to drive the eNPP1-mediated accumulation of extracellular PP i . A significant limitation in addressing this issue is the very efficient coupling between release of ATP into the cell surface microenvironment and its rapid metabolism by eNPP1 and other ecto-ATPases (28) . We have previously characterized the functional colocalization of ATP release pathways and eNPP activity during receptormediated stimulation of ATP release from human 1321N1 astrocytes (3, 24) . Significant accumulation of ATP in the bulk extracellular compartment was observed only when eNPP activity was inhibited by MeATP. In contrast, accumulation of submicromolar ATP in the cell surface microenvironment was measured in the absence of eNPP inhibition using a surfacelocalized luciferase sensor that effectively competed with eNPP for the released ATP. In the present study, we observed that extracellular ATP in the conditioned bulk medium compartment of VSMC was steadily maintained in the 1-2 nM range in the absence of ecto-ATPase inhibitors but at higher levels, ranging from 10 -80 nM, in the presence of MeATP. These results suggest that eNPP1 is in close proximity to ATP release sites in VSMC. This model of continuous ATP release and eNPP1-dependent hydrolysis is further supported by the sustained and MeATP-sensitive increase in extracellular PP i by VSMC.
The ability of reduced temperature to attenuate this continuous ATP release from nominally unstimulated VSMC (Fig. 6 ) initially suggested that constitutive exocytosis of Golgi-derived secretory vesicles might provide the pathway for ATP export. Recent studies by Lazarowski and colleagues have . Extracellular PPi accumulation by VSMC maintained under tissue culture conditions. VSMC were cultured in serum-supplemented medium as described in EXPERIMENTAL PROCEDURES. Media samples were assayed for PPi levels (F) at the indicated days following transfer of the VSMC to fresh culture medium. Data points represent means Ϯ SE of triplicates from a representative experiment repeated 3 times using passage 2 VSMC. Day 0 represents addition of fresh growth media to VSMC that were seeded 3 days prior. ■, PPi levels in serum-containing tissue culture media; ᮀ, PPi levels in serum-free tissue culture media.
demonstrated that a BFA-sensitive pathway underlies the constitutive release of UDP-glucose from several cell types (extracellular UDP-glucose functions as an agonist for G i -coupled P2Y 14 receptors) (26, 30) . However, using similar BFA treatment protocols, we failed to observe any significant attenuation of ATP and PP i accumulation in the conditioned medium of VSMC. In addition to exocytosis, cells can release ATP by mechanisms that involve facilitated efflux of the cytosolic ATP pool via channels or transporters (see review in Ref. 29) . Given the very favorable electrochemical driving force for ATP efflux, even low-frequency opening of such channels can deliver significant amounts of ATP to extracellular compartments.
Multiple transport proteins or conductances have been suggested as "ATP channels," including some ATP-binding cassette-family transporters, volume-regulated anion channels, maxi-anion channels, and plasma membrane variants of the mitochondrial voltage-dependent anion channel porins (29) . However, there is growing support for the involvement of so-called hemichannels, composed of protein subunits from the well-characterized connexin (Cx) family or the recently described pannexin (Px) family (1, 9, 19, 20, 35, 36, 54) . Although Cx-based channels are generally associated with the transcellular movement of molecules through gap junction channels, Cx (and Px) hemichannels at nonjunctional membrane sites can also be gated to the open state to act as possible conduits for ATP and other small organic metabolites. VSMC express multiple connexins, including Cx43. In preliminary studies, we have observed that extracellular accumulation of ATP and PP i is significantly attenuated in VSMC treated with 100 M carbenoxolone, a nonselective inhibitor of connexin and pannexin channels. This suggests that low-frequency opening of such hemichannels may comprise a major ATP release pathway in these cells. Previous studies have indicated that the gating of connexin gap junction channels is sensitive to temperature (6, 7) and that this might underlie the attenuated accumulation of ATP and PP i observed at 23°C versus 37°C. Alternatively, the lower temperature may act via indirect effects on the homeostasis of ions (e.g., H ϩ or Ca 2ϩ ) that allosterically modulate hemichannel gating.
Many recent studies have shown increased activity of Cx-or Px-based hemichannels in response to various types of mechanical stimulation, such as fluid shear, cell swelling, or direct non-lytic deformation of the plasma membrane (2, 12, 49, 53, 62) . In this regard, unavoidable mechanical stimulation accompanies routine manipulations used in our experimental assays including 1) the initial transfer of VSMC from growth medium to assay medium and 2) periodic removal of extracellular medium samples for analysis of ATP and PP i content. These seemingly innocuous manipulations may generate mechanical stimuli sufficient to gate nonjunctional hemichannels or other mechanosensitive channels with appreciable permeability to ATP. The possible role of mechanical stimulation as a regulator of the ATP/eNPP1-mediated pathway for PP i accumulation is mechanistically appealing given the basal physiological state of VSMC within the aorta and other calcification-prone elastic arteries. These cells undergo constant cyclic mechanical perturbation due to the repetitive systolic stretch and diastolic recoil entrained by the cardiac cycle. Thus, future experiments should test the effects of graded cyclic mechanical strain on both the ATP/eNPP1 and the ANK pathways used by VSMC for the autocrine regulation of extracellular PP i levels.
